Exact Sciences to Participate in September Investor Conferences
Exact Sciences Corp. (Nasdaq: EXAS), a leading cancer screening and diagnostic test provider, has announced its participation in two upcoming investor conferences. The company will be present at the Wells Fargo Healthcare Conference in Boston on September 4, 2024, with a fireside chat scheduled for 3:45 p.m. ET. Additionally, Exact Sciences will participate in the Baird Global Healthcare Conference in New York on September 11, 2024, with a fireside chat at 10:15 a.m. ET.
Investors are invited to join the webcasts of these events, which will be accessible through the investor relations section of Exact Sciences' website at www.exactsciences.com. These conferences provide an opportunity for the company to engage with investors and share insights into its operations and future prospects in the healthcare sector.
Exact Sciences Corp. (Nasdaq: EXAS), un importante fornitore di test diagnostici e di screening per il cancro, ha annunciato la sua partecipazione a due prossime conferenze per investitori. L'azienda sarà presente alla Wells Fargo Healthcare Conference a Boston il 4 settembre 2024, con una chiacchierata informale programmata per le 15:45 ET. Inoltre, Exact Sciences parteciperà alla Baird Global Healthcare Conference a New York il 11 settembre 2024, con una chiacchierata informale alle 10:15 ET.
Gli investitori sono invitati a seguire le dirette web di questi eventi, che saranno accessibili tramite la sezione relazioni con gli investitori del sito web di Exact Sciences all'indirizzo www.exactsciences.com. Queste conferenze offrono un'opportunità all'azienda di interagire con gli investitori e condividere approfondimenti sulle sue operazioni e prospettive future nel settore sanitario.
Exact Sciences Corp. (Nasdaq: EXAS), un proveedor líder de pruebas de diagnóstico y detección de cáncer, ha anunciado su participación en dos próximas conferencias para inversores. La empresa estará presente en la Wells Fargo Healthcare Conference en Boston el 4 de septiembre de 2024, con una charla programada para las 3:45 p.m. ET. Además, Exact Sciences participará en la Baird Global Healthcare Conference en Nueva York el 11 de septiembre de 2024, con una charla a las 10:15 a.m. ET.
Se invita a los inversores a unirse a las transmisiones en vivo de estos eventos, que serán accesibles a través de la sección de relaciones con inversores del sitio web de Exact Sciences en www.exactsciences.com. Estas conferencias brindan una oportunidad para que la empresa interactúe con los inversores y comparta ideas sobre sus operaciones y perspectivas futuras en el sector de la salud.
엑자트 사이언스(Corp. EXAS, Nasdaq)는 암 조기 발견 및 진단 검사의 선도적 제공업체로서, 두 개의 다가오는 투자자 회의에 참석한다고 발표했습니다. 이 회사는 2024년 9월 4일 보스턴에서 열리는 웰스 파고 헬스케어 컨퍼런스에 참석하며, 오후 3시 45분 ET에 파이어사이드 챗이 예정되어 있습니다. 또한, 엑자트 사이언스는 2024년 9월 11일 뉴욕에서 열리는 베어드 글로벌 헬스케어 컨퍼런스에도 참가하며, 오전 10시 15분 ET에 파이어사이드 챗이 있습니다.
투자자들은 이 행사들의 웹 캐스트에 참여해 주시기를 초대받으며, 이는 엑자트 사이언스의 웹사이트 www.exactsciences.com의 투자자 관계 섹션을 통해 접근할 수 있습니다. 이 컨퍼런스는 회사가 투자자와 소통하고 의료 분야에서의 운영 및 미래 전망에 대한 통찰을 공유할 수 있는 기회를 제공합니다.
Exact Sciences Corp. (Nasdaq: EXAS), un fournisseur leader de tests de dépistage et de diagnostic du cancer, a annoncé sa participation à deux prochaines conférences pour investisseurs. La société sera présente à la Wells Fargo Healthcare Conference à Boston le 4 septembre 2024, avec un entretien informel prévu à 15h45 ET. De plus, Exact Sciences participera à la Baird Global Healthcare Conference à New York le 11 septembre 2024, avec un entretien à 10h15 ET.
Les investisseurs sont invités à rejoindre les webcasts de ces événements, qui seront accessibles via la section des relations avec les investisseurs du site d'Exact Sciences à l'adresse www.exactsciences.com. Ces conférences offrent l'occasion à l'entreprise d'interagir avec les investisseurs et de partager des idées sur ses opérations et ses perspectives d'avenir dans le secteur de la santé.
Exact Sciences Corp. (Nasdaq: EXAS), ein führender Anbieter von Krebsvorsorge- und Diagnosetests, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen bekannt gegeben. Das Unternehmen wird am 4. September 2024 an der Wells Fargo Healthcare Conference in Boston teilnehmen, mit einem Fireside Chat um 15:45 Uhr ET. Darüber hinaus wird Exact Sciences am 11. September 2024 an der Baird Global Healthcare Conference in New York teilnehmen, mit einem Fireside Chat um 10:15 Uhr ET.
Investoren sind eingeladen, an den Webcasts dieser Veranstaltungen teilzunehmen, die über den Bereich für Investor Relations auf der Website von Exact Sciences unter www.exactsciences.com zugänglich sind. Diese Konferenzen bieten dem Unternehmen die Möglichkeit, mit Investoren in Kontakt zu treten und Einblicke in seine Geschäftstätigkeit und zukünftigen Perspektiven im Gesundheitssektor zu teilen.
- None.
- None.
-
Wells Fargo Healthcare Conference,
Boston
Fireside chat on Wednesday, September 4, 2024 at 3:45 p.m. ET
-
Baird Global Healthcare Conference,
New York
Fireside chat on Wednesday, September 11, 2024 at 10:15 a.m. ET
The webcasts can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240828766318/en/
Erik Holznecht
Exact Sciences Corp.
investorrelations@exactsciences.com
608-800-6605
Source: Exact Sciences Corp.
FAQ
When is Exact Sciences (EXAS) participating in the Wells Fargo Healthcare Conference?
What time is Exact Sciences' (EXAS) fireside chat at the Baird Global Healthcare Conference?
How can investors access the webcasts of Exact Sciences' (EXAS) investor conference presentations?
Which investor conferences will Exact Sciences (EXAS) be attending in September 2024?
